SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/37A3CF937361CFC326DB13D5B7DC7C25BF76C0BB134B1CD1DD95C386AFD27FC44D1C3DBF2524F4014536AF70D6AE72F5>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/37A3CF937361CFC326DB13D5B7DC7C25BF76C0BB134B1CD1DD95C386AFD27FC44D1C3DBF2524F4014536AF70D6AE72F5
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/37A3CF937361CFC326DB13D5B7DC7C25BF76C0BB134B1CD1DD95C386AFD27FC44D1C3DBF2524F4014536AF70D6AE72F5
http://www.w3.org/2000/01/rdf-schema#comment
"Data indicate that 5-lipoxygenase (5LO) inhibitor zileuton had a significant reduction in Amyloid beta-Protein (Abeta) levels."
xsd:string
http://purl.uniprot.org/uniprot/#_FDD8E6A87213D1CAF4C778ADFD42B1DC39C82585F71DF2378F9756E529D0E873688A9884B7EDA0A38639E99C6511C864
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/37A3CF937361CFC326DB13D5B7DC7C25BF76C0BB134B1CD1DD95C386AFD27FC44D1C3DBF2524F4014536AF70D6AE72F5
http://purl.uniprot.org/uniprot/Q3TWF3
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/37A3CF937361CFC326DB13D5B7DC7C25BF76C0BB134B1CD1DD95C386AFD27FC44D1C3DBF2524F4014536AF70D6AE72F5
http://purl.uniprot.org/uniprot/#_Q3TWF3-mappedCitation-23951061
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/37A3CF937361CFC326DB13D5B7DC7C25BF76C0BB134B1CD1DD95C386AFD27FC44D1C3DBF2524F4014536AF70D6AE72F5